A live archive of receipt-bound excerpts from company earnings calls. No generated thesis, no recommendation — just the recorded language, its source coordinates, and a direct path into the ticker dossier or live Terminal.来自公司财报电话会的可追溯摘录档案。没有生成式投资结论，也没有推荐——只有原始表述、来源坐标，以及进入个股档案或实时终端的直接入口。
Start free in Terminal免费开始使用终端Browse the full archive page by page. Search on this page by ticker, period, category, or speaker; every card preview is a verbatim call excerpt.分页浏览完整档案。在本页按代码、期间、分类或发言人搜索；每张卡片预览均为电话会原文摘录。
Showing records 1–96 of 436.显示第 1–96 条，共 436 条。
“Beginning in 2027 and beyond, we expect IFP growth to outpace spend growth, a key driver of operating leverage and profitability.”
“We now expect approximately $60 million of productivity versus our prior expectation of $75 million, reflecting ongoing absorption headwinds from lower residential volumes and the delayed timing of some material cost reduction initiatives as resources were shifted to tariff mitigation.”
“The $0.69 improvement was due to higher revenue volume, $0.36, improved program performance, $0.20, lower corporate and other expense, including the non-cash preferred deemed dividend, $0.24, offset by $0.11 of net product line sales and investment gains.”
“We expect 21% organic growth, a contribution of 6% to growth from the Basler acquisition, and a 1% FX headwind.”
“Each quarter of this execution moves us closer to our sub 60% SG&A target, and as vehicle margins stabilize and volumes improve, that leverage flows straight to earnings.”
“Overall, revenues are expected to increase in the mid-single-digit range for the full year, with operating margin in the mid- to high teens range, reflecting the impact of lower margins in the second quarter due to elevated shipyard activity and the market specific pricing dynamics for the 80,000-100,000 barrel portion of our fleet.”
“This includes full year TRYNGOLZA product sales of $100 million-$110 million, with TRYNGOLZA expected to return to revenue growth in the second half of this year as the sHTG launch gains momentum, and full year DAWNZERA product sales of $110 million-$120 million, with continued growth forecasted in the second half of this year.”
“For the third quarter of 2026, we expect 5%-7% organic growth, adjusted EBITDA margin in the 27%-27.5% range, and adjusted EPS of $2.20-$2.25.”
“We are updating our reported revenue outlook to a range of $1.654 billion-$1.695 billion and reported growth of 1.1%-3.7% to reflect the FX impact of a stronger U.S.”
“It's also great to see top-of-funnel growth picked up as we added nearly 1 million funded customers in the quarter.”
“Based on our strong results year to date and confidence for the remaining two quarters, we have increased our 2026 FFO outlook to a range of $3.46-$3.70 per share, which equates to $3.58 at the midpoint, an increase of $0.04 per share.”
“Cash costs outperformed the low end of the 2026 guidance range despite external cost pressures, positioning the operations well to achieve the full year guidance range.”
“This outlook includes net interest expense of approximately $45 million, a normalized effective tax rate of around 24%, and increased CapEx of approximately $40 million as we continue to invest in upgrading our operational capabilities.”
“So far this year, we sold over $80 million of turbos for industrial applications, and we expect further growth in the second half with a view that is now about $200 million of sales in industrial for the full year.”
“As a result of year-to-date performance, we have increased our gross margin estimate to approximately 59.7%, 120 basis points higher than our previous guidance and is 100 basis points higher than the full-year 2025 gross margin.”
“Looking at our updated gross margin expectations for full year 2026, excluding the tariff recovery impact, we now expect gross margins to be near the low end of our previous guidance range of 38.5%-39.5%, given the higher sales mix of C&I segment sales in our forecast.”
“As a result of our second quarter outperformance, we are raising our full year 2026 net sales guidance to $680 million-$700 million, an increase of $60 million-$65 million over our prior guidance of $620 million-$635 million.”
“You're leaving Pete, you're leaving your successor, and you're leaving us with the medium-term 2026, 2028 outlook goals and targets, the mid-single digit organic growth, high teens to 20% adjusted EBIT margin, high single digits to low double-digit EPS growth, 90% free cash flow conversion.”
“In Combat, we expect revenue of about $9.8 billion, coupled with a 13.8% operating margin.”
“Second, net interest margin declined to 3.78%, driven primarily by a 7 basis points decline in loan portfolio yields and the continued impact of an elevated funding cost environment.”
“Our revised guidance for the third quarter and full year 2026 reflects the AI-related demand and traffic headwinds observed in recent weeks, which have continued into Q3, impacting our entire marketplace, ongoing weakness in categories most exposed to AI automation, and declining services revenue.”
“Finally, we are raising our full-year 2026 adjusted EPS guidance to $2.95-$3.05, reflecting our solid first-half performance and our confidence in the trajectory of the business.”
“Backlog burn of 8.6% in the second quarter was higher sequentially, in line with our expectations, driven primarily by service fee growth in our clinical pharmacology business, as well as sequentially higher passthrough revenue in both the clinical pharmacology and clinical development businesses.”
“We believe the first quarter of 2026 marked a trough for our service revenue growth rate, and we anticipate a positive trajectory in our growth rates going forward.”
“At our investor day, we introduced our new target model with a goal of doubling revenues to $1.6 billion, achieving 55% non-GAAP gross margin and more than doubling non-GAAP earnings per share to $5 per share by 2030.”
“Looking at each of the assets, at NT, traffic was impacted by the capacity improvement construction works and declined 0.6% in the second quarter and 2% in the first half of the year.”
“Turning quickly to demand, total customer load increased approximately 2% in the quarter on a weather-adjusted basis, with industrial load increasing over 4%, with growth across most sectors, but especially in metals, oil and gas, and chemicals, reflecting strengthening order activity and tailwinds from the AI and data center infrastructure build-outs.”
“Second quarter financial performance at First Commonwealth and highlights include core EPS of $0.44, up $0.07 over the first quarter, a core ROA of 1.46%, and core pre-tax, pre-provision ROA of 2.14%, a core efficiency ratio of 52.24%, and a net interest margin of 4.01%, which expanded nine basis points as a function of lower deposit and funding costs, higher loan yields, and securities purchases.”
“We believe if supply continues to decrease and we don't have any significant change in customer, the risks of which Jeff outlined, we think we can get back to kind of historical levels of revenue growth between 3%-4%.”
“We are also raising our adjusted diluted EPS guidance to a range of $2.25-$2.29, representing approximately 16%-18% year-over-year growth, up from our prior guidance of $2.18-$2.23.”
“For the full year, we would expect to see a modestly higher growth rate in non-comps relative to what we have experienced over the last couple of years.”
“We remain firmly on track to meet our 2026 adjusted EPS guidance and longer-term outlooks.”
“For the third quarter, we anticipate continuing strength, including MRR growth of 9%-11% year-over-year, total revenue growth of 10%-12% year-over-year, and an adjusted EBITDA margin of 51%.”
“Reflecting the strength of our same-store operations, continued operational momentum across our portfolio, and the ability of our local teams to deliver strong clinical outcomes that deepen referral relationships and support sustainable growth, along with the contribution from acquisitions, we are increasing our annual 2026 earnings guidance to $7.75-$7.85 per diluted share, up from our previous guidance of $7.48-$7.62, which we increased last quarter.”
“As shown on the slide, in the first half 2026, EBITDA reached $685 million, up 4% year-on-year, driven mainly by stronger gross margin performance in our integrated business, while second quarter EBITDA was lower than last year, reflecting weaker hydrology and lower gas sales.”
“Importantly, through portfolio high grading and strategic moves like our recently announced Mercuria joint venture, this volume growth will translate directly into cash flow, underpinning our primary target, growing our upstream free cash flow per barrel by more than 50% by 2030.”
“Our full-year capital expenditure expectations are set between $85 million and $95 million, focused directly on expansion projects in Central America, fresh-cut growth in Europe, investments in the Del Monte Foods business, and technology investments.”
“We grew revenues to EUR 17.2 billion, well on track to reach our full-year ambition of around EUR 33 billion.”
“Adjusted EBITDA margin was 10.4%, a decrease from 12.4%, primarily driven by increased retail revenue per unit resulting from the traditional gross revenue treatment mentioned previously.”
“With the increased productivity we are delivering at each of Christina Lake, Foster Creek, and Sunrise, we are increasing our full-year production guidance for the company to the range of 970,000 BOE-1,010,000 BOE per day, with no change to our capital investment guidance.”
“Our healthcare platform business generates more than $1.1 billion in annual revenue, through the first half of 2026, grew faster than the overall company while delivering substantially higher margins.”
“Together with our year-to-date activity, this leads us to raise our investment volume guidance by over $100 million to a new range of $300 million-$400 million.”
“We expect cash interest of approximately $125 million, in line with prior guidance, and cash taxes of approximately $105 million, up from prior guidance mainly due to increased profitability.”
“Given our strong first half performance, record backlog levels, and continued confidence in both our core and acquired businesses, we are raising our full year adjusted EPS outlook by $0.20 at the midpoint to a range of $6.85-$7.05 per share.”
“The results for the quarter, the team delivered volume growth of 4%, revenue growth of 13%, an operating ratio of 61.6%, earnings of $1.27, which is an increase of 13%.”
“This year, with the combined impact of our structural gross margin expansion, cost discipline, and accelerated synergy realization, we are confident in increasing our full-year adjusted EBITDA margin target by another 100 basis points versus our June outlook to approximately 14%.”
“We expect growth to continue and have increased our 2026 revenue guidance to a range of $1.1 billion to $1.2 billion.”
“Operating income increased by 39.2% to a record $43 million year-over-year, demonstrating strong operating leverage as we continue to balance expense discipline with targeted investment in areas of our business that will drive future growth.”
“With respect to profitability guidance for 2026, we now expect non-GAAP adjusted diluted earnings per share in the range of $4.48-$4.60 compared to our prior guidance range of $4.30-$4.45.”
“For Q3, we anticipate cost of sales to be just under 30%, as sequentially higher avocado pricing will be offset with menu pricing.”
“We expect to derive attractive shareholder returns from this transaction, as ES&H has built an outstanding reputation with its customers over a 30-year history.”
“Our organic growth has exceeded the 4%-7% target range established in 2023, with the focus on full year 2028.”
“Anticipated revenue growth, excluding the impact of the Medicare Cap, improves from the previous guidance range of 6.5%-7.5% to a revised range of 8.25%-9.25%.”
“Reflecting Öksüt's strong performance through the H1 of 2026, we have increased our full year gold production guidance to between 120,000 and 135,000 ounces, representing a 9% increase at the midpoint from our previous guidance.”
“SOP grew 28% with notable operating leverage, which we expect to moderate in the back half of the year given the timing of costs.”
“Those are the factors that give us confidence in year-over-year adjusted EBITDA growth in the third quarter and support our full-year adjusted EBITDA guidance of $850 million-$1 billion.”
“We will always have some marginal availability given the fact that we do 10-year leases and we have some, what I would refer to as larger clients, and if they choose to relocate or we can't accommodate their growth, then we'll have some downtime.”
“For seaborne metallurgical, we expect volume of 1.9 million-2.1 million tons, as Metropolitan has a longwall move and a scheduled longwall outage will reduce sales at Shoal Creek.”
“The challenge, as you know, has been in the two areas, EP and WATCHMAN, that had hyper growth, unusually differentiated growth in 2024 and 2025, and now we expect more pressure in 2026 and 2027.”
“On a year-over-year basis, I would like to highlight growth of 13% in cards, 15% in customer finance, and 11.5% in small and mid-sized enterprises.”
“We think a lot of that product that was done in 2021/2022 is refueling the pipeline for transaction sales, all at a reset basis.”
“Dyna's EBITDA margin was up from 4.6% in the prior quarter from sales growth and the tariff refund.”
“We expect to deploy 50% or more of our cumulative free cash flow generated between 2026 and 2030 towards stock repurchases and continue to reduce our common stock outstanding.”
“In terms of the other key assumptions underlying our guidance, for the full year 2026, we now estimate a revenue tailwind from currency of approximately $45 million, down from approximately $50 million previously, as exchange rates have moderated.”
“Incorporates approximately a $3 non-GAAP diluted EPS impact of charges associated with IPR&D and milestones, including the Q2 TJ Bio transaction, the Ionis milestone associated with achieving the first patient dosed in STELLAR-1, our pivotal Phase III salanersen study in SMA, and the pending RayThera transaction associated with the addition of a Phase I immunology asset into the early-stage pipeline, which is expected to close in Q3, and the expected full-year 2026 $0.85 dilution associated with the Apellis transaction, again, largely driven by the impact of financing costs.”
“Combined, this gives us the confidence to increase our 2026 revenue outlook to $3 billion, representing approximately 13% growth and achieving a historical high for the company.”
“Even if we adjust for revenue seasonality and expense phasing, management believe that the full-year run rate for Solta segment profit now stands at approximately $330 million, which is approximately a $100 million increase where compared to 2025.”
“Taking into account Q2 results, the current margin and macro environment and forward curves, we now expect full year 2026 adjusted EPS in a range of $9.25-$9.75, which is up from our previous range of $9-$9.50.”
“Getting down to business, today we're going to cover our financial results for the second quarter, updated guidance for the full year 2026, some recent developments in our innovation pipeline.”
“Non-GAAP gross profit of $90 million increased 14% year-over-year, representing a gross profit yield of approximately 68% on incremental Cloud Communications revenue growth.”
“As the remaining securities proceeds are invested and the targeted loan sale closes, we expect the go-forward margin to come in around 3.30%.”
“The current accident year loss ratio was 68.3%, or 67.9% in the prior year quarter, as we recognized increased competitive pressures in A&H employer stop loss business.”
“As reported this morning in our earnings release, second quarter revenue was $69.7 million, up 23.1% versus the second quarter of 2025, reflecting broad-based growth across all three target markets.”
“On a year-over-year basis, revenue declined 5.6% organically, reflecting the impact of the discrete factors we had discussed previously.”
“We anticipate exiting the year with more than 200 driverless trucks in operation, which translates to an approximately $80 million revenue run rate for our Transportation-as-a-Service business.”
“We continue to take a disciplined and deliberate approach to capital allocation, distributing two-thirds of earnings while executing on targeted and measured growth.”
“Our contract mining partner CMPs is also performing well, with our year-to-date sales margin of 43% above the top end of guidance.”
“Taken together, these factors support our outlook for relative stability and earnings and our decision to maintain a stable quarterly dividend, building on our track record of stable or growing regular quarterly dividends for 17 consecutive years.”
“Collectively, the organizational changes are expected to generate approximately $40 million in annualized cost savings while improving our ability to serve customers and scale for future growth.”
“As we look into the third quarter, we anticipate sales to increase roughly in the 20% range compared to the second quarter as we participate in the beginnings of a variety of new program launches for our customers.”
“Adjusted operating margin expanded 180 basis points to 32.9%, and adjusted earnings per share increased to $0.94.”
“As a result, we are reaffirming our 2026 full year guidance, including mid-single digit or greater organic revenue growth, 70-80 basis points of margin expansion, strong adjusted earnings growth, and double-digit free cash flow growth.”
“product revenues declined to $32.2 million from $36.5 million in Q2 2025, driven by ongoing pricing pressure in the competitive generic market, partially offset by higher product volumes.”
“For the full-year, we expect revenue of $528 million to $531 million, representing growth of 19%-19.7%, and adjusted EBITDA of $96 million to $98 million, or 18.3% margin at the midpoint, reflecting expanded operating leverage as we scale the business.”
“Q2 2026 revenues and clear aligner volumes were in line with our outlook, while clear aligner ASPs and non-GAAP operating margin of 22.9% exceeded our expectations.”
“Given the strong operating fundamentals and increased confidence heading into the second half of the year, together with the accretion from our external growth, we raised our full-year earnings guidance again this quarter, now targeting approximately 10% year-over-year FFO growth at the midpoint.”
“Reflecting our strong first half performance and positive outlook for the business, we are raising our full-year earnings guidance to $16.80 per share, not including any additional gains on asset sales.”
“Based on the first half performance and continued momentum, we now expect volume growth between 38%-40% this year, which is well above our initial target of more than 30%.”
“Our updated full year guidance now reflects revenue in a range of $3.4 billion-$3.45 billion, adjusted EBITDA in a range of $590 million-$615 million, adjusted EPS in a range of $1.45-$1.60, and operating cash flow in a range of $350 million-$400 million.”
“Large tenant demand is increasing, including an RFP that we expect to get for 100,000 to 120,000 feet, which could figure not into Tower 3, but actually Tower 1 activity.”
“Our strong first half performance, along with the benefits from share repurchases and higher margins, more than offset the revenue headwind from electric metering delays and gives us confidence to raise the EPS range from $5.35-$5.60 to $5.55-$5.70.”
“While our outlook conservatively reflects the near-term impacts of the regional conflict in the Middle East and a more gradual, elongated recovery in activity levels, as we have said before, we project second half of 2026 adjusted EBITDA margins to exceed 24%, with fourth-quarter margins exceeding 26%.”
“Turning to our Q2 results, XPLR's portfolio generated approximately $523 million in Adjusted EBITDA and $257 million in free cash flow before growth.”
“Bruce, just as a reminder, we've talked about the $18 million of synergy target over 18 months, and that would equate to a 300 basis point margin expansion for FirstFleet, which would bridge the gap between the FirstFleet adjusted operating income margins compared to our organic Dedicated fleet.”
“Year-to-date, we generated $69.1 million of free cash flow, down from $82.7 million in the same period last year, which reflects the previously communicated headwind from the end-of-life announcement of our on-prem platform, and also includes approximately $11.9 million of acquisition-related costs related to the accounting treatment of our acquisitions.”
“My question is, should we expect an acceleration on net income in the H2 of 2026 and, as a consequence, an acceleration of dividends?”
Try a ticker, period, category, or a call speaker.请尝试代码、期间、分类或电话会发言人。
This is a transcript-only, historically incomplete publication. Releases, filings, slides, consensus and price reaction are visibly marked as not joined; lower-evidence packets remain held instead of being inferred.这是仅基于电话会文本且历史覆盖尚不完整的发布。新闻稿、申报文件、演示材料、一致预期和股价反应均明确标注为未接入；证据不足的数据包会被暂缓，而非由推断补齐。